IL69203A0 - Improvements in formulations of vinca alkaloids - Google Patents

Improvements in formulations of vinca alkaloids

Info

Publication number
IL69203A0
IL69203A0 IL69203A IL6920383A IL69203A0 IL 69203 A0 IL69203 A0 IL 69203A0 IL 69203 A IL69203 A IL 69203A IL 6920383 A IL6920383 A IL 6920383A IL 69203 A0 IL69203 A0 IL 69203A0
Authority
IL
Israel
Prior art keywords
formulations
vinca alkaloids
vinca
alkaloids
Prior art date
Application number
IL69203A
Other versions
IL69203A (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL69203A0 publication Critical patent/IL69203A0/en
Publication of IL69203A publication Critical patent/IL69203A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL69203A 1982-07-19 1983-07-12 Stable,ready-to-use aqueous formulations of vinca dimer alkaloid salts for intravenous injections IL69203A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39965482A 1982-07-19 1982-07-19
US47607783A 1983-03-17 1983-03-17

Publications (2)

Publication Number Publication Date
IL69203A0 true IL69203A0 (en) 1983-11-30
IL69203A IL69203A (en) 1986-03-31

Family

ID=27016716

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69203A IL69203A (en) 1982-07-19 1983-07-12 Stable,ready-to-use aqueous formulations of vinca dimer alkaloid salts for intravenous injections

Country Status (16)

Country Link
AU (1) AU553514B2 (en)
BE (1) BE897280A (en)
CH (1) CH654744A5 (en)
DE (1) DE3324964A1 (en)
FR (1) FR2531860B1 (en)
GB (1) GB2125292B (en)
HK (1) HK43087A (en)
HU (1) HU191538B (en)
IE (1) IE55388B1 (en)
IL (1) IL69203A (en)
IT (1) IT1170152B (en)
LU (1) LU84910A1 (en)
NL (1) NL184146C (en)
NZ (1) NZ204868A (en)
PH (1) PH19098A (en)
SE (1) SE463804B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (en) * 1986-04-25 1989-06-02 Pf Medicament STABLE AQUEOUS SOLUTION OF VINCRISTINE SULFATE
FR2623089B1 (en) * 1987-11-13 1990-04-27 Pf Medicament PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION OF NAVELBINE
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
FR2910812B1 (en) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa LYOPHILIZED INJECTABLE PHARMACEUTICAL COMPOSITIONS OF HEMI-SYNTHETIC STABLE VINCA ALKALOID DERIVATIVES AT AMBIENT TEMPERATURE
EP3777861A1 (en) * 2015-08-01 2021-02-17 Sun Pharmaceutical Industries Ltd Dosage form of vinca alkaloid drug

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
US3749784A (en) * 1972-05-03 1973-07-31 Lilly Co Eli Psoriasis treatment
GB2020180B (en) * 1978-05-08 1982-08-25 Nelson Res & Dev Ophthalmic compositions containingcolchicine or vinblastinr
US4208414A (en) * 1978-06-05 1980-06-17 Eli Lilly And Company Vinblastine in rheumatoid arthritis
US4259242A (en) * 1978-10-10 1981-03-31 Eli Lilly And Company Method of preparing vindesine sulfate
HU181940B (en) * 1979-11-02 1983-11-28 Richter Gedeon Vegyeszet Process for producing solutions of vincane derivatives for parentheral application
OA06421A (en) * 1980-06-10 1981-09-30 Omnium Chimique Sa Process for the preparation of N- (vinblastinoyl-23) derivatives of amino acids and peptides.

Also Published As

Publication number Publication date
NL184146B (en) 1988-12-01
AU553514B2 (en) 1986-07-17
NL8302552A (en) 1984-02-16
GB2125292B (en) 1986-06-04
LU84910A1 (en) 1985-04-17
NZ204868A (en) 1986-10-08
PH19098A (en) 1986-01-02
IT1170152B (en) 1987-06-03
IL69203A (en) 1986-03-31
FR2531860A1 (en) 1984-02-24
NL184146C (en) 1989-05-01
IE831646L (en) 1984-01-19
HK43087A (en) 1987-06-05
GB2125292A (en) 1984-03-07
DE3324964A1 (en) 1984-01-19
AU1689183A (en) 1984-01-26
HU191538B (en) 1987-03-30
IE55388B1 (en) 1990-08-29
IT8321644A0 (en) 1983-06-15
SE463804B (en) 1991-01-28
SE8304009L (en) 1984-01-20
SE8304009D0 (en) 1983-07-15
FR2531860B1 (en) 1986-09-26
DE3324964C2 (en) 1991-03-14
BE897280A (en) 1984-01-13
GB8319146D0 (en) 1983-08-17
CH654744A5 (en) 1986-03-14

Similar Documents

Publication Publication Date Title
ZW20383A1 (en) Compounds compositions and methods of use therefor
DE3372476D1 (en) Preparation of p-nitrosodiphenylamine
GB2132996B (en) Oral composition and abrasive therefor
IL66113A0 (en) Pharmaceutical formulations containing ergot alkaloids
GB2134786B (en) Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
DE3377695D1 (en) Use of a protoberberine alkaloid and composition containing same
GB8321167D0 (en) Composition of matter
IL69203A0 (en) Improvements in formulations of vinca alkaloids
ZA835081B (en) Formulations of vinca alkaloids
GB2125041B (en) Ergot alkaloids
DE3370796D1 (en) Alpha-iminodiacetonitriles and methods for their preparation
GB8317345D0 (en) Preparation of arylethylamines
GB2126230B (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols preparation and use thereof
GB2152506B (en) Vinca alkaloids
PH21234A (en) Ergot alkaloids
DE3360784D1 (en) Preparation of nitro-olefins
GB2120656B (en) Preparation of thio-bis-phenols
DE3374560D1 (en) Cyanoalkylpiperazines and methods for their preparation and use
DE3276871D1 (en) Preparation of 6-deoxy-d-fructose and 6-deoxy-l-sorbose
GB2115811B (en) Ergot alkaloids
GB2121405B (en) Preparation of bischoline naphathalene-disulphonates
GB8305444D0 (en) Benzyl ether derivatives of pentites
GB8311446D0 (en) Preparation of 3-hydroxy-benzodiazepinones
ZA83955B (en) Ergot alkaloids
DE3368617D1 (en) Preparation of 2-t-butyl-5-chloropyrimidine

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired